Death Anxiety Perceived Parenting Maternal Symptoms and Health-Related Quality of Life among Duchenne Muscular Dystrophy and Multiple Sclerosis Adolescents

Abstract

Aim: Death anxiety, which may arise from the anticipation of death, includes aspects such as fear of the death process. Death anxiety in adolescents with serious or terminal illnesses was generally studied with adolescents undergoing cancer treatment. However, there have been few studies in the literature on death anxiety and the factors that may influence it in adolescents with Duchenne muscular dystrophy and multiple sclerosis. This study aims to compare death anxiety, perceived parenting, maternal psychiatric symptoms, and health-related quality of life in adolescents diagnosed with duchenne muscular dystrophy and multiple sclerosis. Materials and Methods: The population of the study, which is a relational screening model, consisted of 19 adolescents with muscular dystrophy and 22 adolescents with multiple sclerosis, aged between 14-17, and their mothers. Data were collected through a brief symptom inventory, death anxiety scale, quality of life scale for children, and parental attitude inventory. ANOVA, chi-square, correlation, and regression analysis analyzed data. Results: It was found that adolescents with muscular dystrophy had higher death anxiety, lower quality of life, less psychological autonomy from their parents, and higher psychiatric symptoms of their mothers compared to adolescents with multiple sclerosis. It has been found that death anxiety is predicted by physical functionality, psychological autonomy, and the mother’s depressive symptoms. Conclusion: It’s essential to periodically evaluate the psychiatric symptoms of DMD’s mothers, especially the death anxiety symptoms of adolescents with DMD

Keywords

• Muscular Dystrophy Duchenne
• Multiple Sclerosis
• Death Anxiety
• Adolescence

References

1. 1. Tomer A. Death anxiety in adult life: Theoretical perspectives. Death Studies, 1992; 16: 6, 475–506. doi.org/10.1080/07481189208252594.
2. 2. Ayten A. Death Anxiety among University Students: A Comparison Study on Turkish and Jordanian Students. Journal of Academic Research in Religious Sciences. 2009; 9:1, 85-108. (Turkish)
3. 3. Nagy MH. The Child's Theories Concerning Death Article. The Journal of Genetic Psychology. 1948;73,3-27. doi: 10.1080/08856559.1948.10533458.
4. 4. Vazifeh Doust M, Hojjati H, Farhangi H. Effect of spiritual care based on Ghalbe Salim on anxiety in adolescents with cancer. J Relig Healt. 2020; 59:6, 2857-2865. doi: 10.1007/s10943-019-00869-9.
5. 5. Farella Guzzo M, Gobbi G. Parental Death During Adolescence: A Review of the Literature. OMEGA - Journal of Death and Dying. 2023; 87:4, 1207-1237. https://doi.org/10.1177/00302228211033661.
6. 6. Soleimani MA, Bahrami N, Allen KA, Alimoradi Z. Death anxiety in patients with cancer: A systematic review and meta-analysis. Eur J Oncol Nurs. 2020; 48:101803. doi: 10.1016/j.ejon.2020.101803. 7.
7. 7. Templer DI, Awadalla A, Al-Fayez G, Frazee J, Bassman L, Connell HJ, Arikawa H, Abdel-Khalek AM. Construction of a Death Anxiety Scale–Extended. OMEGA - Journal of Death and Dying.2006; 53:3, 209-226. https://doi.org/10.2190/BQFP-9ULN-NULY-4JDR.
8. 8. Alroughani R, Boyko A. Pediatric multiple sclerosis: a review. BMC Neurol. 2018 Mar 9;18(1):27. doi: 10.1186/s12883-018-1026-3. PMID: 29523094; PMCID: PMC5845207.

9. 9. Labauge P. Do disease-modifying drugs (DMD) have a positive impact on the occurrence of secondary progressive multiple sclerosis? No. Rev Neurol. 2020; 176(6):494-496. doi: 10.1016/j.neurol.2020.03.004.
10. 10. Chrastin J, Haroková M. End of Life in Boys and Young Men With Duchenne Muscular Dystrophy – The Perspective of Dying Men and Their Families: A Systematic Review and Thematic Synthesis of Qualitative Evidence. Omega (Westport). 2023; 5:302228231186358. doi: 10.1177/00302228231186358.
11. 11. Huang M, Chen T, Wang Y, Zhou C, Cao J, Lu X, Zeng H. Chronic pain, psychological distress, and quality of life in males with Duchenne muscular dystrophy. Dev Med Child Neurol. 2023; 65:5, 640-654. doi: 10.1111/dmcn.15404.
12. 12. Apter-Levy Y, Zagoory-Sharon O, Feldman R. Chronic Depression Alters Mothers’ DHEA and DEHA-to-Cortisol Ratio: Implications for Maternal Behavior and Child Outcomes. Front Psychiatry. 2020; 22:11,728. doi: 10.3389/fpsyt.2020.00728.
13. 13. Storm Van's Gravesande K, Blaschek A, Calabrese P, Rostásy K, Huppke P, Kessler J J, Kalbe E, Mall V; MUSICADO Study group. Fatigue and depression predict health-related quality of life in patients with pediatric-onset multiple sclerosis. Mult Scler Relat Disord. 2019; 36:101368. doi: 10.1016/j.msard.2019.08.010.
14. 14. Allen J, Hauser S, O’Connor T, Bell K. Prediction of peer-rated adult hostility from autonomy struggles in adolescent–family interactions. Child Youth Psyh.2002; 14, 123–137. doi: 10.1017/S0954579402001074.
15. 15. Memık NÇ, Ağaoğlu B, Coşkun A, Ünerı ÖŞ, Karakaya I. The Validity and Reliability of the Turkish Pediatric Quality of Life Inventory for Children 13-18 Years Old. Turk Psikiyatri Derg. 2007; 18: 4, 353-363. PMID: 18066726.
16. 16. Karaca F, YILDIZ M. Validity and Reliability Study of the Turkish Translation of the Thorson Powell Death Anxiety Scale in the Normal Population. Tabula Rasa. 2001; 1, 43-55. (Turkish).
17. 17. Şahin N, Durak A. Brief Symptom Inventory- BSI: Adaptation for Turkish youth. Turkish Journal of Psychology. 1994; 9:31, 44- 56. (Turkish)
18. 18. Yılmaz A. Validity and reliability study of the parental attitude scale. Journal of Child and Youth Mental Health. 2000; 7:3, 160-172. (Turkish). doi: 10.4274/jpr.galenos.2018.23855.
19. 19. Edwards NC, Munsell M, Menzin J, Phillips AL. Factors associated with early initiation of disease-modifying drug treatment in newly-diagnosed patients with multiple sclerosis. Curr Med Res Opin. 2018;34(8):1389-1395. doi:10.1080/03007995.2018.1447452.
20. 20. Opstal SHY, Jansen M, van Alfen N, de Groot IJ. Health-related quality of life and its relation to disease severity in boys with Duchenne muscular dystrophy: satisfied boys, worrying parents—a case-control study. J Child Neurol. 2014; 29:11, 1486–1495. doi: 10.1177/0883073813506490.
21. 21. Kohler M, Clarenbach CF, Boüni L, Brack T, Russi EW, Bloch KE. Quality of life, physical disability, and respiratory impairment in Duchenne muscular dystrophy. Am J Respir Crit Care Med. 2005;172: 8, 1032–1036. doi: 10.1164/rccm.200503-322OC.
22. 22. Kulas HM. Examining parental utilization of and barriers to psychological interventions in the Duchenne Muscular Dystrophy community. [Doctoral dissertation]. 2021. University of Pittsburgh. doi.10.1111/dmnc.12938.
23. 23. Çırpan Kantarcıoğlu, Arzu, et al. Evaluation of Anger, Externalizing Problems, Features of Mother-Child Relationship And Maternal Mood and Stress Behavior of Pediatric Leukemia Patients. Turk J Child Adolesc Ment Health. 2016, 23.1: 29-40. (Turkish)
24. 24. Landfeldt E, Lindgren P, Bell CF et al. Health-related quality of life in patients with Duchenne muscular dystrophy: a multinational, cross-sectional study. Dev Med Child Neurol. 2016;58: 5, 508–515. doi: 10.1111/dmcn.12938.
25. 25. Çırpan Kantarcıoğlu A. A Difficult but Compelling Subject: Giving Bad News by Doctors. Journal of Uludağ University Faculty of Medicine. 2018; 44:3, 217-219. doi.org/10.32708/uutfd.415489. (Turkish)
26. 26. Wilski Maciej et al. Health-related quality of life in multiple sclerosis: Links to acceptance, coping strategies, and disease severity. Disability and health journal. 2019; 12:4, 608-614. doi: 10.1016/j.dhjo.2019.06.003.
27. 27. Blaschek, Astrid, et al. Fatigue and depression predict health-related quality of life in patients with pediatric-onset multiple sclerosis. Multiple sclerosis and related disorders. 2019; 36, 1013. doi: 10.1016/j.msard.2019.08.01.
28. 28. Kredentser, Maia S., and Harvey Max Chochinov. Psychotherapeutic Considerations for Patients With Terminal Illness. American Journal of Psychotherapy, APT. 2020; (73): 137–43. doi.org/10.1176/appi.psychotherapy.20190048.
29. 29. Söderman A, Östlund U, Werkander Harstäde C, Blomberg K. Dignity-conserving care for persons with palliative care needs — identifying outcomes studied in research: An integrative review. Palliative and Supportive Care. 2020;18(6):722-740. doi:10.1017/S1478951520000139.
30. 30. Karslıoğlu EH. Psychotherapeutic Interventions for Terminally Ill Cancer Patients. In Çayköylü A (editor). Psycho-oncology Psychosocial Perspective on the Cancer Patient. 1st Edition. Ankara: Türkiye Clinics; 2021. p.28-33. (Turkish).